| Filed On | Filing |
|---|---|
| 24 Mar 2023 |
8-K/A: Completion of Acquisition or Disposition of Assets
On January 23, 2023, Leap Therapeutics, Inc. (the “Company”) filed a Current Report on Form 8-K (the “Original Form 8-K”) disclosing the Company’s acquisition of Flame Biosciences, Inc., a Delaware corporation, pursuant to an Agreement a... |
| 15 Apr 2020 |
8-K/A: Departure/Election of Directors or Officers; Compensation
This Executive Employment Agreement (“Agreement”) is made and entered into as of this 10th day of April, 2020, by and between Leap Therapeutics, Inc., a Delaware corporation (the “Company”), and Douglas E. Onsi (hereinafter, the “Executi... |
Loading...